Advanced Prostate Cancer: EMA Approves Abiraterone Combined With Hormone Therapy as First-line Treatment

News   Nov 22, 2017 | Original story from The Institute of Cancer Research

 
Advanced Prostate Cancer: EMA Approves Abiraterone Combined With Hormone Therapy as First-line Treatment

Credit: The Institute of Cancer Research

 
 
 

RELATED ARTICLES

New Microscope Captures Detailed 3-D Movies of Cells Deep Within Living Systems

News

Merging lattice light sheet microscopy with adaptive optics reveals the most detailed picture yet of subcellular dynamics in multicellular organisms.

READ MORE

Protein Target Identified That Could Prevent Strokes

News

Scientists have identified a protein, called GPR68, that senses blood flow and tells small blood vessels called arterioles when to dilate. The researchers believe medications that activate GPR68 could one day be useful to treat medical conditions, including ischemic stroke.

READ MORE

Neuropeptide Y Y1 Receptor Structure Solved, Offers New Opportunities for Anti-obesity Drug Discovery

News

Scientists solve the crystal structure of Neuropeptide Y Y1 Receptor, offering new opportunities for anti-obesity drug discovery.

READ MORE

 

Comments | 1 ADD COMMENT

Leonard Adams | Dec 08, 2017

I had no idea about this. My urologist is very opposed to drugs that have not undergone through rigorous clinical trials, I have BPH and he prescribed me alpharise health. It has been a very effective cure for my bph symptoms.


Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE